123 related articles for article (PubMed ID: 8881790)
1. Recurrence of thin melanoma: how effective is follow-up?
Moloney DM; Gordon DJ; Briggs JC; Rigby HS
Br J Plast Surg; 1996 Sep; 49(6):409-13. PubMed ID: 8881790
[TBL] [Abstract][Full Text] [Related]
2. Follow-up requirements for thick cutaneous melanoma.
Sylaidis P; Gordon D; Rigby H; Kenealy J
Br J Plast Surg; 1997 Jul; 50(5):349-53. PubMed ID: 9245869
[TBL] [Abstract][Full Text] [Related]
3. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma, evaluation of clinical follow up by questionnaire survey.
Regan MW; Reid CD; Griffiths RW; Briggs JC
Br J Plast Surg; 1985 Jan; 38(1):11-4. PubMed ID: 3967106
[TBL] [Abstract][Full Text] [Related]
5. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
6. Is long-term follow-up justified after excision of a thin melanoma (less than or equal to 1.5 mm)? A retrospective analysis of 206 patients.
Brandt SE; Welvaart K; Hermans J
J Surg Oncol; 1990 Mar; 43(3):157-60. PubMed ID: 2314103
[TBL] [Abstract][Full Text] [Related]
7. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients.
Gutzmer R; Al Ghazal M; Geerlings H; Kapp A
Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648
[TBL] [Abstract][Full Text] [Related]
8. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
9. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report.
Esmaeli B; Youssef A; Naderi A; Ahmadi MA; Meyer DR; McNab A;
Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):96-101. PubMed ID: 12644753
[TBL] [Abstract][Full Text] [Related]
10. [Lymphatic metastases in the parotid region from malignant skin neoplasm of the head: considerations for surgical treatment based on personal clinical experience].
Tullio A; Bianchi B; Sesenna E
Acta Otorhinolaryngol Ital; 2001 Feb; 21(1):44-9. PubMed ID: 11434222
[TBL] [Abstract][Full Text] [Related]
11. Data on first recurrence after treatment for malignant melanoma in a large patient population.
Fusi S; Ariyan S; Sternlicht A
Plast Reconstr Surg; 1993 Jan; 91(1):94-8. PubMed ID: 8416544
[TBL] [Abstract][Full Text] [Related]
12. Contemporary treatment of malignant melanoma.
Cady B; Legg MA; Redfern AB
Am J Surg; 1975 Apr; 129(4):472-82. PubMed ID: 1124847
[No Abstract] [Full Text] [Related]
13. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients.
Machet L; Nemeth-Normand F; Giraudeau B; Perrinaud A; Tiguemounine J; Ayoub J; Alison D; Vaillant L; Lorette G
Br J Dermatol; 2005 Jan; 152(1):66-70. PubMed ID: 15656802
[TBL] [Abstract][Full Text] [Related]
14. [Local recurrence and metastasis of thin malignant melanomas (less than or equal to 1mm)].
Garbe C; Stadler R; Orfanos CE
Hautarzt; 1989 Jun; 40(6):337-43. PubMed ID: 2753709
[TBL] [Abstract][Full Text] [Related]
15. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis, follow-up and prognosis of malignant melanomas by thermography.
Bourjat P; Gautherie M; Grosshans E
Bibl Radiol; 1975; (6):115-27. PubMed ID: 1180842
[TBL] [Abstract][Full Text] [Related]
17. [Melanoma in HIV patients: 14 cases].
Qasmi S; Sutra-Loubet C; Maubec E; Boitier F; Duvillard P; Carlotti A; Marinho E; Jacobelli S; Franck N; Gorin I; Vacher-Lavenu MC; Bouscarat F; Crickx B; Dupin N; Avril MF
Ann Dermatol Venereol; 2010 Dec; 137(12):769-74. PubMed ID: 21134578
[TBL] [Abstract][Full Text] [Related]
18. Status of the Regional Nodal Basin Remains Highly Prognostic in Melanoma Patients with In-Transit Disease.
Gonzalez AB; Jakub JW; Harmsen WS; Suman VJ; Markovic SN
J Am Coll Surg; 2016 Jul; 223(1):77-85.e1. PubMed ID: 27118347
[TBL] [Abstract][Full Text] [Related]
19. Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
Lee AY; Droppelmann N; Panageas KS; Zhou Q; Ariyan CE; Brady MS; Chapman PB; Coit DG
Ann Surg Oncol; 2017 Apr; 24(4):939-946. PubMed ID: 27804026
[TBL] [Abstract][Full Text] [Related]
20. Desmoplastic melanoma: a clinico-pathological review.
Devaraj VS; Moss AL; Briggs JC
Br J Plast Surg; 1992; 45(8):595-8. PubMed ID: 1493532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
